Brief: Cyclo Therapeutics Signs Agreement With Worldwide Clinical Trials To Conduct Alzheimer’S Disease Clinical Trial
30/10/2019 12:26
Oct 30 (Reuters) - Ctd Holdings Inc CTDH.PK :
* CYCLO THERAPEUTICS SIGNS AGREEMENT WITH WORLDWIDE CLINICAL
TRIALS TO CONDUCT ALZHEIMER’S DISEASE CLINICAL TRIAL
* CTD HOLDINGS INC - TRIAL WILL EVALUATE SAFETY AND EFFICACY
OF
COMPANY'S TRAPPSOL(®) CYCLO™ DRUG IN ALZHEIMER'S DISEASE
Source text for Eikon: ID:nBw8T6VmMa
Further company coverage: CTDH.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug